ADHD: Declare the Diagnosis or the Medication?

An adult ADHD diagnosis, on its own, is one of the weaker signals you can put on a life insurance application. It is not a condition that shortens life in the direct, mechanical way a heart or liver problem can, and for most people who declare the diagnosis and a settled prescription and nothing more alarming, cover is assessed on standard terms. Does ADHD affect life insurance in the UK? Less than the wording of the form makes you fear at midnight with the mortgage offer sitting next to it.

The nervousness around it comes from what travels alongside the diagnosis rather than from the diagnosis itself. A stimulant prescription, the low mood or anxiety that often gets treated at the same time, an old note about drinking more than you should have during a bad year — those are the things an underwriter reads closely. So the honest instruction for declaring ADHD on an insurance application is easy to say and harder to sit with: put down the diagnosis, put down the medication, and answer the questions around it truthfully, because that surrounding history is where the terms are actually decided.

The short answer: the diagnosis alone barely moves the needle

Underwriting is the business of estimating how likely someone is to die within the term of a policy, and pricing accordingly. Read through that lens, an uncomplicated adult ADHD diagnosis does not carry much weight. It is common, it is increasingly diagnosed in adults who functioned for decades without a label, and by itself it is not strongly associated with early death from disease. An insurer looking at a diagnosis, a stable prescription and an otherwise clean history has little reason to load the premium.

That matters because the surge in adult diagnoses over the past few years means a great many people are meeting this question for the first time in their late thirties or forties — often at exactly the moment they are buying a house and being asked to arrange cover against the mortgage. If that is you, the useful thing to understand is that the diagnosis is rarely the problem. It is a starting point for a few follow-up questions, not a verdict.

ADHD is assessed the way most conditions are: on its specifics rather than its name. That is the same logic an underwriter applies to a heart rhythm condition like atrial fibrillation on a life insurance application, where the diagnosis matters far less than what the investigations showed. The label opens the file; the detail decides the terms.

Yes, you have to declare it — and what "it" is

There is no version of this where you get to leave the diagnosis off. If the application asks whether you have been diagnosed with a medical or psychological condition, whether you take any regular medication, or whether you have been referred to a specialist — and a full application asks all three — then ADHD is caught by the question, and so is the medication, and so is the psychiatrist or the clinic that assessed you.

Declaring "it" means more than ticking a box marked ADHD. Expect the form, or the follow-up, to ask when you were diagnosed, who diagnosed you, what you take and at what dose, whether the dose is settled or still being adjusted, and whether any other condition was picked up at the same time. Answer the question that is actually in front of you, accurately and without editorialising. You are not required to volunteer a running commentary, but you must not shave the truth to make the answer look tidier.

This duty comes from the Consumer Insurance (Disclosure and Representations) Act 2012, which replaced the old standard of "utmost good faith" with something fairer to consumers: you must take reasonable care not to make a misrepresentation, and the insurer has to ask clear questions rather than expect you to guess what matters. That cuts both ways. You are not penalised for failing to disclose something the insurer never asked about — but where it does ask, plainly, about diagnoses and medication, an ADHD diagnosis is squarely within the question.

The stimulant prescription, and why it prompts questions

Most adults treated for ADHD are on a stimulant — methylphenidate, lisdexamfetamine or dexamfetamine — or sometimes a non-stimulant such as atomoxetine. Seeing one of these on the form will prompt questions, and it is worth understanding that this is not the underwriter hunting for a reason to charge more. A prescription tells them two useful and slightly contradictory things at once: that a clinician judged the condition significant enough to treat, and that it is being actively managed and reviewed.

What they will usually want to know is which medicine you take, whether the dose has settled, who reviews it, and whether the reason for the prescription was the ADHD alone or something alongside it. A stable, long-standing prescription reviewed at sensible intervals reads reassuringly. A dose still being titrated, or a very recent start, may simply mean the underwriter wants to see things settle — which is a delay, not a decline.

Do not be tempted to come off your medication before applying in the belief it will read better. It will not, and it can read worse: an untreated condition looks less controlled than a treated one, and stopping a medicine that was working is exactly the kind of instability an underwriter is trained to notice. Treat the prescription as part of an honest picture of a managed condition, because that is what it is.

What actually changes the terms: what sits alongside the ADHD

If your terms come back rated, or postponed, the reason is far more likely to be found in the company ADHD keeps than in the ADHD itself. Adult ADHD frequently sits alongside depression and anxiety, and sometimes alongside a period of heavier drinking or drug use, or a history of self-harm. Those are the entries an underwriter weighs seriously, because each has a clearer relationship with mortality risk than the core diagnosis does.

This is why an application that mentions ADHD and a settled prescription often passes without fuss, while one that mentions ADHD, a recent depressive episode, a spell of heavy drinking and a medication change in the last few months attracts real scrutiny. The scrutiny is aimed at the cluster, not the ADHD label sitting inside it. The same underwriting logic runs through a related mental-health question such as applying for life insurance with bipolar disorder, where the assessment turns on length of stability, admission history and monitoring rather than the diagnosis alone.

Two neighbouring topics are worth reading if they apply to you. If your history includes a period of heavier drinking that a clinician recorded, understanding how many units to declare on a life application will help you answer the alcohol question truthfully, because that answer can matter more to the outcome than the ADHD does. And if part of your instinct is to keep some of this private, it is worth being clear-eyed about what an insurer can and cannot ask for — a useful contrast is a predictive genetic result, which under the industry code an insurer cannot ask you to disclose even where you carry a BRCA result. A diagnosis and a prescription enjoy no such protection: they are ordinary medical information, and they are fair game for the questions.

A private diagnosis still counts — and usually reaches your GP anyway

A great deal of adult ADHD is diagnosed privately, sometimes through a clinic the reader never mentioned to their GP, and this produces a recurring hope: if my own doctor does not know, do I have to say? The answer is yes, and the reasoning is worth following, because the disclosure duty is not defined by what appears in your NHS notes.

The question on the form asks whether you have been diagnosed, not whether your GP recorded it. A private diagnosis is still a diagnosis. Beyond that, the practical reality is that these things rarely stay siloed: clinic assessment letters are routinely copied to the GP, and the shared-care arrangements that let a GP continue prescribing a controlled stimulant mean the diagnosis and the medication almost always land in the GP record in the end. So if the insurer later seeks a report, with your consent, from your GP, the entry is likely to be there.

An insurer cannot simply help itself to your medical history. It needs your written consent to approach your GP, and you have rights over the report before it goes anywhere. Under the Access to Medical Reports Act 1988, which applies in England, Wales and Scotland, you can ask to see a report your own doctor has prepared for the insurer before it is sent, and ask for factual errors to be corrected. The point is not that disclosure is a trap — it is that the honest answer and the record are very likely to match, so an accurate answer costs you nothing and protects the claim your family may one day need to make.

If you leave it off: what non-disclosure actually triggers

The worst outcome here is not a rated premium. It is a policy that behaves impeccably while you are alive to hear nothing about it, and then fails at the one moment it exists for. If you leave a diagnosis or a prescription off the form and the insurer can later show a qualifying misrepresentation, the 2012 Act sets out what happens, and it depends on how the answer went wrong.

A careless mistake — a genuine misunderstanding of the question — is dealt with proportionately: the insurer does what it would have done had it known, which can mean a reduced payout rather than a refused one. A deliberate or reckless misrepresentation is treated far more harshly, and can mean the claim is refused and the premiums kept. The distinction between careless and reckless is exactly the ground you do not want your grieving partner arguing over with an insurer years from now.

Set against that, a loading — if there even is one — is a small, known, survivable cost. And a decline or a rating from one insurer is not the market's answer. Insurers differ in how they weight mental-health and neurodevelopmental histories, so if one comes back with terms you did not expect, an FCA-authorised broker who understands where these cases are best placed can often find a better home for the application. When you are ready to test the real position rather than the worst case in your head, you can get life insurance quotes and have a broker price the cover against your actual history and your mortgage.

Scotland and Northern Ireland

The underwriting principles here are UK-wide: the disclosure duty under the 2012 Act, the way a stimulant prescription is read, and the weight given to co-occurring conditions do not change when you cross a border. What differs is the machinery around your medical records.

The Access to Medical Reports Act 1988 — your right to see a GP's report before it reaches the insurer — applies in England, Wales and Scotland. Northern Ireland is governed by its own equivalent, the Access to Personal Files and Medical Reports (Northern Ireland) Order 1991, which gives broadly similar rights under a different statute. If you are in Northern Ireland and an insurer asks to approach your GP about an ADHD diagnosis or your medication, it is the 1991 Order, not the 1988 Act, that sets out what you are entitled to see. The practical advice is identical wherever you live: consent to the report, ask to see it, and make sure it is accurate before it is used.

For the wider picture of how a diagnosis, a medication or a job sits on an application, our guide to getting cover with a history, a condition or a job pulls the individual questions together in one place.

Frequently asked questions

Do I have to declare an ADHD diagnosis?

Yes, if the application asks about diagnosed conditions, medication or specialist referrals — and most applications ask about all three. Declare the diagnosis and the medication. A private diagnosis still counts as a diagnosis, and where your GP has been informed or issues the prescription under a shared-care arrangement, it will appear in any consented medical report in any case.

Does ADHD lead to higher premiums?

The diagnosis alone is a weak indicator of mortality risk, and many applicants are assessed on standard terms. Where the terms do change, it is usually because of what sits alongside the ADHD — depression, substance use, a self-harm history or a recent unstable period — rather than the ADHD itself. A rating from one insurer is not the whole market.

What if I was diagnosed privately and my GP does not know?

You must still answer the question accurately, because the duty to disclose is not limited to what appears in your NHS record. In practice, private clinic letters are often copied to the GP, and shared-care arrangements for stimulant medication mean the prescription usually reaches the GP record anyway. The honest answer and the record are very likely to match, so accuracy costs you nothing and protects the claim.